It appeared that the GFP-positive shCITED2-AML cells that eventually did engraft did not show a reduction of CITED2 levels and therefore most likely have escaped sufficient knockdown of CITED2 (Figure 1d), indicating that CITED2 knockdown impacts the survival and maintenance of leukemia initiating cells. The gene discussed is CITED2; the disease is leukemia.